Oxymatrine exhibits anti-tumor activity in gastric cancer through inhibition of IL-21 R-mediated JAK2/STAT3 pathway

被引:30
|
作者
Huang, Yanxia [1 ,2 ]
Zhang, Jing [2 ]
Wang, Ge [2 ]
Chen, Xiaoyu [2 ]
Zhang, Rui [2 ]
Liu, Hui [2 ]
Zhu, Jinshui [2 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Gastroenterol, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China
来源
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY | 2018年 / 32卷
关键词
gastric cancer; growth; IL-21R; JAK2; oxymatrine; STAT3; INTERLEUKIN-21; RECEPTOR; IN-VITRO; GROWTH; CELLS; LYMPHOMA; PROLIFERATION;
D O I
10.1177/2058738418781634
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Oxymatrine (OMT) as a type of alkaloids collected from Sophora flavescens Ait exerts some biological functions including anticancer properties. Here, we investigated the therapeutic effects of OMT in gastric cancer cells (HGC 27 and AGS). As a result, the exposure of gastric cancer (GC) cells to OMT contributed to the suppression of cell proliferation and invasion. Interleukin 21 receptor (IL-21R) was identified to be differentially expressed between OMT treatment group (4mg/mL) and control group (0 mg/mL), and knockdown of IL-21 R repressed cell proliferation and invasion via inactivation of the JAK2/STAT3 pathway. The rescue experiment showed that IL-21R overexpression attenuated the anti-tumor effects of OMT through activation of the JAK2/STAT3 pathway. Moreover, the expression of IL-21R was significantly upregulated in GC samples compared with the adjacent normal tissues and associated with overall survival (OS) and tumor recurrence of GC patients. Taken together, in this study, we evaluated the anti-tumor effects of OMT on GC by investigating proliferation and invasion ability changes, and our findings show that OMT exhibits effects via regulation of JAK/STAT signaling pathway. Through the mechanism study, we may enlighten the potential therapeutic target for treatment of GC.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression
    Kaitao Yuan
    Jinning Ye
    Zhenguo Liu
    Yufeng Ren
    Weiling He
    Jianbo Xu
    Yulong He
    Yujie Yuan
    Journal of Experimental & Clinical Cancer Research, 39
  • [32] RETRACTED: Gastrokine 2 Regulates the Antitumor Effect of JAK2/STAT3 Pathway in Gastric Cancer (Retracted Article)
    Zhou, Yu
    Xu, Shan
    Liu, Jiao
    Zhu, Yaping
    Zhu, Yaxin
    Li, Wei
    Ling, Hui
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [33] Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression
    Yuan, Kaitao
    Ye, Jinning
    Liu, Zhenguo
    Ren, Yufeng
    He, Weiling
    Xu, Jianbo
    He, Yulong
    Yuan, Yujie
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [34] LncRNA SNHG16 Functions as an Oncogene by Sponging MiR-135a and Promotes JAK2/STAT3 Signal Pathway in Gastric Cancer
    Wang, Xinguo
    Kan, Jie
    Han, Jun
    Zhang, Wenyan
    Bai, Liyan
    Wu, Hao
    JOURNAL OF CANCER, 2019, 10 (04): : 1013 - 1022
  • [35] Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer
    Cao, Ya
    Wang, Jinglong
    Tian, Hua
    Fu, Guo-Hui
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [36] Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways
    Wu, Liangrong
    Qian, Chenchen
    Zhang, Weiqi
    Shi, Mengyun
    Chen, Xiuxiu
    Wang, Yi
    Lin, Feng
    PHYTOMEDICINE, 2023, 116
  • [37] miR-451a suppression of IL-6R can inhibit proliferation and increase apoptosis through the JAK2/STAT3 pathway in multiple myeloma
    Zhong, Ling
    Xu, Zhuyu
    Jin, Xin
    He, Yuan
    Zhang, Jianbo
    Jiang, Tao
    Chen, Jiao
    ONCOLOGY LETTERS, 2020, 20 (06)
  • [38] A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway
    Zhao, Hong
    Guo, Yuming
    Li, Shu
    Han, Ruiqin
    Ying, Jianming
    Zhu, Hai
    Wang, Yuanyuan
    Yin, Li
    Han, Yuqing
    Sun, Lingzhi
    Wang, Zhaoyi
    Lin, Qingcong
    Bi, Xinyu
    Jiao, Yuchen
    Jia, Hongying
    Zhao, Jianjun
    Huang, Zhen
    Li, Zhiyu
    Zhou, Jianguo
    Song, Wei
    Meng, Kun
    Cai, Jianqiang
    ONCOTARGET, 2015, 6 (31) : 31927 - 31943
  • [39] YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma
    Kong, Jian
    Kong, Fandong
    Gao, Jun
    Zhang, Qiangbo
    Dong, Shuying
    Gu, Fang
    Ke, Shan
    Pan, Bing
    Shen, Qiang
    Sun, Huichuan
    Zheng, Lemin
    Sun, Wenbing
    MOLECULAR CANCER, 2014, 13
  • [40] IL1R2 promotes tumor progression via JAK2/STAT3 pathway in human clear cell renal cell carcinoma
    Liu, Yingting
    Xing, Zhaoyu
    Yuan, Maoling
    Xu, Bin
    Chen, Lujun
    Zhang, Dachuan
    Zhou, You
    Huang, Hao
    Zheng, Xiao
    Zhang, Jinping
    Jiang, Jingting
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 238